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Our hypothesis postulates that the phosphorylated form of histone H1 recognizes and binds preferentially to the amyloid motif of the Aβ peptide 
stabilizing its amyloid-like fibrils aggregation and protecting them against proteolysis, at intracellular and extracellular level.  
This aggregation causes the formation of NFTs and senile plaques, the 
two features defining Alzheimer’s disease. 
the direct binding of Aβ fibrils to C1q enhances the classical 
complement activation via C1q, which exerts a detrimental effect on 
neuronal integrity by the recruitment of activated glia.  
TIMELINE 
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x 
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elaboration 
x 
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with the 
transgenic 
x x 
In vitro tests x x 
Results analysis x 
EXPECTED RESULTS AND CONCLUSIONS 
BIBLIOGRAPHY 
1- Co-localization of both markers in the immunohistochemistry (confirmation of real interaction). 
Then, we could dare to say that inhibition of the interaction between histone H1 and amyloid-like fibrils may impede 
the common characteristics in AD and may therefore represent a potential therapeutic target for its treatment. 
INTRODUCTION 
- Unphosphorylated, binds to the DNA entering and 
exiting the nucleosoma, stabilizing higher order 
chromatin conformations and protecting linker DNA. 
- Its phosphorylation reduces 
its affinity for DNA, promoting 
its release to the cytoplasm. 
-A chronic disorder that causes serious cognitive disability. 
-Characterized by: 
senile plaques: deposition of 
abnormal protein β (Aβ) 
neurofibrillary tangles (NFTs): 
aggregates of hyperphosphorylated 
tau protein 
 loss of synapses and neurons. 
Main goal: define a hypothesis about the implication of histone H1 in the pathological profile of AD and 
attempt to prove it by the use of analytical techniques. 
Histone H1 Alzheimer’s disease (AD) 
Main background 
- Non-nuclear histone H1 is upregulated within the cytoplasm of neurons and astrocytes 
from areas affected by disease as well as amyloid plaques in both prion disease and AD 
but not acute neurodegeneration [1]. 
- H1 was the strongest detected interacting protein to the amyloid-like motifs of Aβ [3]. 
- H1 was identified as a major extracellular candidate released by damaged adult brain 
that causes neurotoxicity and activation of the innate system [2]. 
- An upregulation of Cdk5 (kinasa responsible for H1’s phosphorylation) in neurons with 
early stage AD has been reported. Therefore, it seems feasible that increases in Cdk5 may 
not only abnormally phosphorylate tau but also increase phosphorylated histone H1 [3]. 
AIMS 
1- To demonstrate the real interaction between histone H1 
and aggregated Aβ (immunohistochemistry assay). 
 
2- To prove that it is just the phosphorylated form of H1 
the one in contact with the Aβ aggregates and to 
determine the H1 subtype involved in the process (MALDI 
TOF mass spectrometry analysis). 
 
3- To elaborate a transgenic mice strain by knocking the 
gene codifying for the H1 subtype it and analyze the effect 
of the absence of the histone on both the Aβ aggregation 
and the immune system activation. 
 
4- By inducing Aβ aggregation of synthetic protein β: 
METHODOLOGY 
In vivo tests: comparing wt with C57BL/6-Tg (an AD model) mice  
4.1- To study the effect of H1 phosphorylated and 
unphosphorylated on the Aβ aggregation process 
(Thioflavin T spectroscopic assay) 
4.2- To test the capacity of H1 of protecting Aβ fibrils 
from proteolysis (by exposition to proteolitic enzymes 
and analyzed by capillary electrophoresis with laser-
induced fluorescence detection, CE/LIF). 
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2- The sequenced peptides analyzed by MALDI TOF to correlate with the phosphorylated form of H1 and to one 
of the H1 subtypes defined in the literature. 
3- Absence or decrement of Aβ aggregation and immune system activation in the transgenic strain. 
4- Aβ aggregation and proteolysis resistance only or significantly increased when tests carried on with the 
phosphorylated form of the H1 subtype defined in 2.  
Figures obtained from [4], [5]. 
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